Invincible, but not invisible: imaging approaches toward in vivo detection of cancer stem cells
- PMID: 18539971
- DOI: 10.1200/JCO.2008.16.9573
Invincible, but not invisible: imaging approaches toward in vivo detection of cancer stem cells
Abstract
With evidence emerging in support of a cancer stem-cell model of carcinogenesis, it is of paramount importance to identify and image these elusive cells in their natural environment. The cancer stem-cell hypothesis has the potential to explain unresolved questions of tumorigenesis, tumor heterogeneity, chemotherapeutic and radiation resistance, and even the metastatic phenotype. Intravital imaging of cancer stem cells could be of great value for determining prognosis, as well as monitoring therapeutic efficacy and influencing therapeutic protocols. Cancer stem cells represent a rare population of cells, as low as 0.1% of cells within a human tumor, and the phenotype of isolated cancer stem cells is easily altered when placed under in vitro conditions. This represents a challenge in studying cancer stem cells without manipulation or extraction from their natural environment. Advanced imaging techniques allow for the in vivo observation of physiological events at cellular resolution. Cancer stem-cell studies must take advantage of such technology to promote a better understanding of the cancer stem-cell model in relation to tumor growth and metastasis, as well as to potentially improve on the principles by which cancers are treated. This review examines the opportunities for in vivo imaging of putative cancer stem cells with regard to currently accepted cancer stem-cell characteristics and advanced imaging technologies.
Similar articles
-
Cancer stem cells: an old idea--a paradigm shift.Cancer Res. 2006 Feb 15;66(4):1883-90; discussion 1895-6. doi: 10.1158/0008-5472.CAN-05-3153. Cancer Res. 2006. PMID: 16488983
-
Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype.Clin Cancer Res. 2006 Oct 1;12(19):5615-21. doi: 10.1158/1078-0432.CCR-06-0169. Clin Cancer Res. 2006. PMID: 17020963
-
Cancer stem cells in solid tumors.Semin Cancer Biol. 2010 Apr;20(2):77-84. doi: 10.1016/j.semcancer.2010.03.004. Epub 2010 Apr 3. Semin Cancer Biol. 2010. PMID: 20371287 Review.
-
Cancer stem cells: at the headwaters of tumor development.Annu Rev Pathol. 2007;2:175-89. doi: 10.1146/annurev.pathol.2.010506.091847. Annu Rev Pathol. 2007. PMID: 18039097 Review.
-
Convergent mechanisms in pluripotent stem cells and cancer: implications for stem cell engineering.Biotechnol J. 2013 Apr;8(4):408-19. doi: 10.1002/biot.201200202. Epub 2013 Feb 18. Biotechnol J. 2013. PMID: 23418009 Review.
Cited by
-
Development of a Stable Peptide-Based PET Tracer for Detecting CD133-Expressing Cancer Cells.ACS Omega. 2021 Dec 22;7(1):334-341. doi: 10.1021/acsomega.1c04711. eCollection 2022 Jan 11. ACS Omega. 2021. PMID: 35036703 Free PMC article.
-
In vivo molecular imaging of cancer stem cells.Am J Nucl Med Mol Imaging. 2014 Dec 15;5(1):14-26. eCollection 2015. Am J Nucl Med Mol Imaging. 2014. PMID: 25625023 Free PMC article. Review.
-
Recognition and killing of cancer stem-like cell population in hepatocellular carcinoma cells by cytokine-induced killer cells via NKG2d-ligands recognition.Oncoimmunology. 2015 Aug 31;5(3):e1086060. doi: 10.1080/2162402X.2015.1086060. eCollection 2016 Mar. Oncoimmunology. 2015. PMID: 27141341 Free PMC article.
-
Nanoparticles for cell labeling.Nanoscale. 2011 Jan;3(1):142-53. doi: 10.1039/c0nr00493f. Epub 2010 Oct 11. Nanoscale. 2011. PMID: 20938522 Free PMC article. Review.
-
Exosomes from BM-MSCs increase the population of CSCs via transfer of miR-142-3p.Br J Cancer. 2018 Sep;119(6):744-755. doi: 10.1038/s41416-018-0254-z. Epub 2018 Sep 17. Br J Cancer. 2018. PMID: 30220706 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
